Literature DB >> 25869081

Residualization Rates of Near-Infrared Dyes for the Rational Design of Molecular Imaging Agents.

Cornelius Cilliers1, Jianshan Liao1, Lydia Atangcho1, Greg M Thurber2,3.   

Abstract

PURPOSE: Near-infrared (NIR) fluorescence imaging is widely used for tracking antibodies and biomolecules in vivo. Clinical and preclinical applications include intraoperative imaging, tracking therapeutics, and fluorescent labeling as a surrogate for subsequent radiolabeling. Despite their extensive use, one of the fundamental properties of NIR dyes, the residualization rate within cells following internalization, has not been systematically studied. This rate is required for the rational design of probes and proper interpretation of in vivo results. PROCEDURES: In this brief report, we measure the cellular residualization rate of eight commonly used dyes encompassing three core structures (cyanine, boron-dipyrromethene (BODIPY), and oxazine/thiazine/carbopyronin).
RESULTS: We identify residualizing (half-life >24 h) and non-residualizing (half-life <24 h) dyes in both the far-red (~650-680 nm) and near-infrared (~740-800 nm) regions.
CONCLUSIONS: This data will allow researchers to independently and rationally select the wavelength and residualizing nature of dyes for molecular imaging agent design.

Entities:  

Keywords:  Cyanine dyes; Fluorescently labeled antibodies; Fluorophore retention; Multi-modality imaging; Protein metabolism; Receptor internalization

Mesh:

Substances:

Year:  2015        PMID: 25869081      PMCID: PMC4938006          DOI: 10.1007/s11307-015-0851-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  23 in total

1.  Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.

Authors:  Scott M Knowles; Kirstin A Zettlitz; Richard Tavaré; Matthew M Rochefort; Felix B Salazar; David B Stout; Paul J Yazaki; Robert E Reiter; Anna M Wu
Journal:  J Nucl Med       Date:  2014-02-06       Impact factor: 10.057

Review 2.  The design and application of residualizing labels for studies of protein catabolism.

Authors:  S R Thorpe; J W Baynes; Z C Chroneos
Journal:  FASEB J       Date:  1993-03       Impact factor: 5.191

Review 3.  Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging.

Authors:  Simon-Peter Williams
Journal:  AAPS J       Date:  2012-03-31       Impact factor: 4.009

4.  Comparison of Kinetic Models for Dual-Tracer Receptor Concentration Imaging in Tumors.

Authors:  Nazanin Hamzei; Kimberley S Samkoe; Jonathan T Elliott; Robert W Holt; Jason R Gunn; Tayyaba Hasan; Brian W Pogue; Kenneth M Tichauer
Journal:  Austin J Biomed Eng       Date:  2014-03-05

5.  Near IR heptamethine cyanine dye-mediated cancer imaging.

Authors:  Xiaojian Yang; Chunmeng Shi; Rong Tong; Weiping Qian; Haiyen E Zhau; Ruoxiang Wang; Guodong Zhu; Jianjun Cheng; Vincent W Yang; Tianmin Cheng; Maged Henary; Lucjan Strekowski; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2010-04-21       Impact factor: 12.531

6.  New fluorescent markers for the red region.

Authors:  J Arden-Jacob; J Frantzeskos; N U Kemnitzer; A Zilles; K H Drexhage
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2001-09-14       Impact factor: 4.098

7.  Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition.

Authors:  Neal K Devaraj; Rabi Upadhyay; Jered B Haun; Scott A Hilderbrand; Ralph Weissleder
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

Authors:  O W Press; D Shan; J Howell-Clark; J Eary; F R Appelbaum; D Matthews; D J King; A M Haines; P Hamann; L Hinman; D Shochat; I D Bernstein
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

9.  In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.

Authors:  Christian Brand; Dalya Abdel-Atti; Yachao Zhang; Sean Carlin; Susan M Clardy; Edmund J Keliher; Wolfgang A Weber; Jason S Lewis; Thomas Reiner
Journal:  Bioconjug Chem       Date:  2014-06-13       Impact factor: 4.774

Review 10.  Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Authors:  Uwe Seibold; Björn Wängler; Ralf Schirrmacher; Carmen Wängler
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

View more
  16 in total

1.  Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design.

Authors:  Katie F Maass; Chethana Kulkarni; Alison M Betts; K Dane Wittrup
Journal:  AAPS J       Date:  2016-02-24       Impact factor: 4.009

2.  Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer.

Authors:  Madeline T Olson; Nicholas E Wojtynek; Geoffrey A Talmon; Thomas C Caffrey; Prakash Radhakrishnan; Quan P Ly; Michael A Hollingsworth; Aaron M Mohs
Journal:  Mol Cancer Ther       Date:  2020-05-13       Impact factor: 6.261

3.  A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for 18F-Immuno-PET and Fluorescence Imaging.

Authors:  Kirstin A Zettlitz; Christopher M Waldmann; Wen-Ting K Tsai; Richard Tavaré; Jeffrey Collins; Jennifer M Murphy; Anna M Wu
Journal:  J Nucl Med       Date:  2019-03-15       Impact factor: 10.057

4.  Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.

Authors:  Liang Zhang; Greg M Thurber
Journal:  Mol Imaging Biol       Date:  2016-02       Impact factor: 3.488

5.  First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.

Authors:  Rahul Pal; Marisa E Hom; Nynke S van den Berg; Thinzar M Lwin; Yu-Jin Lee; Andrey Prilutskiy; William Faquin; Eric Yang; Srinivas V Saladi; Mark A Varvares; Eben L Rosenthal; Anand T N Kumar
Journal:  Clin Cancer Res       Date:  2022-06-01       Impact factor: 13.801

6.  Improved Tumor Penetration and Single-Cell Targeting of Antibody-Drug Conjugates Increases Anticancer Efficacy and Host Survival.

Authors:  Cornelius Cilliers; Bruna Menezes; Ian Nessler; Jennifer Linderman; Greg M Thurber
Journal:  Cancer Res       Date:  2017-12-07       Impact factor: 12.701

7.  Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.

Authors:  Kirstin A Zettlitz; Wen-Ting K Tsai; Scott M Knowles; Naoko Kobayashi; Timothy R Donahue; Robert E Reiter; Anna M Wu
Journal:  J Nucl Med       Date:  2018-03-30       Impact factor: 10.057

8.  Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for Efficacy.

Authors:  Cornelius Cilliers; Hans Guo; Jianshan Liao; Nikolas Christodolu; Greg M Thurber
Journal:  AAPS J       Date:  2016-06-10       Impact factor: 4.009

9.  Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography.

Authors:  Parul Gupta; Jo-Ann Wentland; Mauricio Leal; Dangshe Ma; Rachel Roach; Antonio Esparza; Lindsay King; Mary E Spilker; Cedo Bagi; Christopher T Winkelmann; Anand Giddabasappa
Journal:  Oncotarget       Date:  2017-07-26

10.  Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design.

Authors:  Liang Zhang; Sumit Bhatnagar; Emily Deschenes; Greg M Thurber
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.